KENNETH F COX

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical DOTHAN, AL NPI 1730158809

General Payments — all program years on this page

$1,483.03

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 89
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $353.88 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $353.8819

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $116.626
Novo Nordisk AS $100.755
ABBVIE INC. $33.602
PFIZER INC. $32.622
Lilly USA, LLC $28.612
Nevro Corp. $22.381
NOVARTIS PHARMACEUTICALS CORPORATION $19.301

By program year

Program yearAmountRecords
2021 $290.3519
2022 $550.6334
2023 $288.1717
2024 $353.8819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086670571 Novartis Pharmaceuticals Corporation $19.30 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100274742 Novo Nordisk Inc $16.94 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100333147 Novo Nordisk Inc $17.01 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100335708 Novo Nordisk Inc $18.62 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100525285 Novo Nordisk Inc $24.09 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100527337 Novo Nordisk Inc $24.09 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104598298 AstraZeneca Pharmaceuticals LP $19.55 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104600032 AstraZeneca Pharmaceuticals LP $19.73 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104657985 AstraZeneca Pharmaceuticals LP $22.53 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212752 AstraZeneca Pharmaceuticals LP $21.25 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105651634 AstraZeneca Pharmaceuticals LP $17.36 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105767740 AstraZeneca Pharmaceuticals LP $16.20 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106960551 ABBVIE INC. $17.50 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106960553 ABBVIE INC. $16.10 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760881 Nevro Corp. $22.38 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131764896 PFIZER INC. $18.03 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132077373 PFIZER INC. $14.59 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135760612 Lilly USA, LLC $14.82 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135760614 Lilly USA, LLC $13.79 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.